MIR4766

Across TCGA pan-cancer cohorts, MIR4766 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated MIR4766 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MIR4766 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MIR4766 expression acts as an unfavorable survival marker, although some lineages such as BLCA and CESC show a favorable association.

BLCA, KIRC, and ACC are the cancer types where MIR4766 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.595	0.476	.008	58	view →
KIRC	DFS	Quartile	III,IV	0.635	0.784	.002	50	view →
ACC	DFS	Tertile	III,IV	0.326	0.722	.006	39	view →
COAD	DFS	Tertile	All	0.521	0.719	.006	36	view →
CHOL	OS	Tertile	IV	0.136	0.829	.008	23	view →
THCA	DFS	Quartile	III,IV	0.355	0.693	.004	20	view →
DLBC	DFS	Tertile	II,III,IV	0.575	0.944	.030	15	view →
SKCM	OS	Tertile	IV	0.167	0.657	.003	9	view →
CESC	DFS	Tertile	II,III,IV	0.812	0.645	.029	8	view →
LGG	DFS	Quartile	All	0.772	0.850	.010	7	view →
ESCA	OS	Quartile	III,IV	0.870	0.417	.029	6	view →
OV	OS	Tertile	IV	0.874	0.695	.041	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

MIR4766–BLCA (DFS)

Open the BLCA breakdown →